An internationally renowned expert in the development of molecular targeted agents, Dr. Baselga has conducted research that led to substantial improvements in survival forpatients with multiple types of breast cancer. His works includes the clinical investigation of novel agents targeting the HER2 and EGF receptors. Dr. Baselga played a leading rolein the pivotal clinical trials of trastuzumab, everolimus, lapatinib, and pertuzumab. Currently, his research focuses on novel anti-HER2 agents, resistance, and the development of PI3K pathway inhibitors.
Dr. Baselga is well known for his caring bedside manner and supportive mentorship of young physician scientists. He cites the translation of research from his laboratory benchto the bedside as one of the most fulfilling parts of his career, highlighting the vast possibilities generated by genetic profiling and constantly evolving personalized therapy. A native of Spain, he founded the Vall d’Hebron Institute of Oncology at Vall d’Hebron University Hospital in Barcelona, and, through his efforts, the Institute has become one ofthe major translational research and cancer treatment centers in Europe. While there, he devoted much of his time to developing preclinical and early-stage clinical studies oftargeted therapies that would revolutionize breast cancer treatment.
Among his many professional responsibilities, Dr. Baselga served as a senior editor of AACR’s journal Clinical Cancer Research and is currently the founding co–editor-in-chief of the AACR journal Cancer Discovery.
2015-2016 President, AACR
2013 International Award for Cancer, Foundation Carregal Ramiro La Rosaleda
2012 Mike Price Gold Medal Award, European Association for Cancer Research
2012 Joseph P. Martin Award, Massachusetts General Hospital
2010 Gold Medal, Queen Sofia Spanish Institute
2010 Bob Pinedo Cancer Care Prize, Society for Translational Oncology
2009-2012 Board of Directors, AACR
2008 AACR-Richard and Hinda Rosenthal Award
2008 King James I Award
2008 Civil Order of Health, Commander with Plaque, Ministry of Health, Spain
2005 Professional Excellence Award in Biomedical Research, Barcelona College of Physicians
2005 Annual Award, European Society of Medical Oncology
2004 Distinguished Alumni Award, Memorial Sloan-Kettering Cancer Institute
1992 PhD, Universitat Autònoma de Barcelona
1982 MD, Universitat Autònoma de Barcelona